Emselex Uniunea Europeană - română - EMA (European Medicines Agency)

emselex

pharmaand gmbh - bromhidrat de darifenacin - urinary incontinence, urge; urinary bladder, overactive - urologicals, medicamente pentru frecvenței urinare si incontinenta - tratamentul simptomatic al incontinenței de urgență și / sau frecvenței și urgenței urinare crescute, care pot apărea la pacienții adulți cu sindrom de vezică urinară hiperactivă.

EMSELEX 15mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

emselex 15mg

novartis pharma gmbh - germania - darifenacinum - compr. cu elib. prel. - 15mg - urologice, med. pt. frecv. urinara crescuta si incontinenta

EMSELEX 7,5mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

emselex 7,5mg

novartis pharma gmbh - germania - darifenacinum - compr. cu elib. prel. - 7,5mg - urologice, med. pt. frecv. urinara crescuta si incontinenta

ORUNGAL 100 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

orungal 100 mg

janssen-cilag spa - italia - itraconazolum - caps. - 100mg - antimicotice de uz sistemic derivati de triazol

Tukysa Uniunea Europeană - română - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - agenți antineoplazici - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Hepcludex Uniunea Europeană - română - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale pentru uz sistemic - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Copiktra Uniunea Europeană - română - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenți antineoplazici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Retsevmo Uniunea Europeană - română - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenți antineoplazici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.